Venture&Growth
Location
Dublin, Ireland
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Irish MedTech company focused on remote monitoring of heart failure patients.
FIRE1 is a connected medical device solutions company dedicated to improving outcomes for people suffering from chronic diseases. Its first product is a novel remote monitoring solution for heart failure patients. FIRE1 is led by an experienced medical devices team who are working closely with researchers, clinicians, patients and payors to help reduce the burden of heart failure.
More Fire1 news
Gilde Healthcare company FIRE1 raises $25 million to revolutionize heart failure home monitoring
Gilde Healthcare leads EUR 40 Million financing in Irish healthtech company FIRE1
Venture&Growth
Inari Medical
US MedTech company focused on removal of blood clots to treat pulmonary embolism or deep vein thrombosis.
Venture&Growth
Spyglass Pharma
Spyglass Pharma was founded in 2019 and is based in Aliso Viejo, California. They are developing a drug delivery platform mounted on an intraocular lens to address mild-moderate glaucoma in patients undergoing cataract surgery. The lead asset utilizes a well-established
Venture&Growth
Big Health
UK-based digital therapy company focused on mental disorders.
